Neurology Specific Literature Search   
 
[home][thesaurus]
    

Enter your terms
above and click
the 'Search' button.
Showing articles 0 to 50 of 1537 Next >>

Filter Applied: MRI,abnormal (Click to remove)

Effect of IV Thrombolysis With Alteplase in Patients with Vessel Occlusion in the WAKE-UP Trial
Neurol 104:e209871, Galinovic,I.,et al, 2024

Noncontrast Computed Tomography vs Computed Tomography Perfusion or Magnetic Resonance Imaging Selection in Late Presentation of Stroke with Large-Vessel Occlusion
JAMA Neurol 79:22-31, Nguyen, T.N.,et al, 2022

Machine Learning Approach to Identify Stroke Within 4.5 Hours
Stroke 51:860-866, Lee, H.,et al, 2020

Thrombolysis for Acute Ischemic Stroke in the Unwitnessed or Extended Therapeutic Time Window
Neurol 94:e1241-e1248, Tsivgoulis, G.,et al, 2020

Intravenous Alteplase for Stroke with Unknown Time of Onset Guided by Advanced Imaging:Systematic Review and Meta-Analysis of Individual Patient Data
Lancet 396:1574-1585, Thomalla,G.,et al, 2020

Multimodal CT or MRI for IV thrombolysis in ischemic stroke with unknown time of onset
Neurol 95:e2954-e2964, Macha, K.,et al, 2020

Lesion Age Imaging in Acute Stroke: Water Uptake in CT Versus DWI-FLAIR Mismatch
Ann Neurol 88:1144-1152, Broocks, G.,et al, 2020

Magnetic Resonance Imaging Versus Computed Tomography Angiography Based Selection for Endovascular Therapy in Patients with Acute Ischemic Stroke
Stroke 50:365-372, Kim, J-T.,et al, 2019

Automated DWI analysis can identify patients within the thrombolysis time window of 4.5 hours
Neurol 90:e1570-e1577, Wouters, A.,et al, 2018

MRI-Guided Thrombolysis for Stroke with Unknown Time of Onset
NEJM 379:611-622, 682, Thomalla, G.,et al, 2018

Intravenous Thrombolysis in Unwitnessed Stroke Onset: MR WITNESS Trial Results
Ann Neurol 83:980-993, Schwamm, L.H.,et al, 2018

Use of Imaging to Select Patients for Late Window Endovascular Therapy
Stroke 49:2256-2260, Albers, G.W., 2018

Significant Period Between Presentation and Diagnosis in Basilar Artery Occlusion
Stroke 46:e79-e81, Organek, N.,et al, 2015

A Trial of Imaging Selection and Endovascular Treatment for Ischemic Stroke
NEJM 368:914-923,952, Kidwell, C.S.,et al, 2013

Endovascular Therapy after Intravenous t-PA versus t-PA Alone for Stroke
NEJM 368:893-903,952, Broderick, J.P.,et al, 2013

A Pragmatic Approach Using Magnetic Resonance Imaging to Treat Ischemic Strokes of Unknown Onset Time in a Thrombolytic Trial
Stroke 43:2331-2335, Song, S.S.,et al, 2012

Fluid-Attenuated Inversion Recovery Evolution Within 12 Hours from Stroke Onset: A Reliable Tissue Clock?
Stroke 41:250-255, 197, Ebinger,M.,et al, 2010

Use of MRI to Estimate the Therapeutic Window in Acute Stroke: Is Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch an EPITHET for Salvageable Ischemic Brain Tissue?
Stroke 40:333-335, Toth,G. &Albers,G.W., 2009

MR Imaging-Based Decision in Thrombolytic Therapy for Stroke on Awakening: Report of 2 Cases
AJRN 29:1314-1316, Iosif,C.,et al., 2008

Evaluation of the Clinical-Diffusion and Perfusion-Diffusion Mismatch Models in DEFUSE
Stroke 38:1826-1830,1718, Lansberg,M.G.,et al, 2007

MRI-Based and CT-Based Thrombolytic Therapy in Acute Stroke Within and Beyond Established Time Windows
Stroke 38:2640-2645, Schellinger,P.D.,et al, 2007

Is Penumbral Imaging Useful for Extending the Treatment Window for Intravenous Tissue Plasminogen Activator?
Ann Neurol 60:499-501, Fisher,M., 2006

Magnetic Resonance Imaging Criteria for Thrombolysis in Acute Cerebral Infarct
Stroke 36:388-397, Hjort, N., et al, 2005

Safety and Efficacy of Intravenous Tissue Plasminogen Activator Stroke Treatment in the 3- to 6-Hour Window Using Multimodal Transcranial Doppler/MRI Selection Protocol
Stroke 36:602-606, Ribo,M., et al, 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1099-1100, 1100, Zivin,J.A., 2005

Perfusion-Weighted Imaging/Diffusion-Weighted Imaging Mismatch on MRI Can Now Be Used to Select Patients for Recombinant Tissue Plasminogen Activator Beyond 3 Hours
Stroke 36:1098-1099,1100, Schellinger,P.D. &Fiebach,J.B., 2005

MRI Screening Before Standard Tissue Plasminogen Activator Therapy Is Feasible and Safe
Stroke 36:1939-1943, Kang,D.-W.,et al, 2005

Are There Time-Dependent Differences in Diffusion and Perfusion Within the First 6 Hours After Stroke Onset?
Stroke 35:2099, Fiehler,J.,et al, 2004

Imaging-Based Decision Making in Thrombolytic Therapy for Ischemic Stroke
Stroke 34:575-583, Schellinger,P.D.,et al, 2003

Thrombolysis in Stroke Beyond Three Hours: Targeting Patients With Diffusion and Perfusion MRI
Ann Neurol 51:11-13,28, Warach,S., 2002

Which Imaging Approach Should be Used for Stroke of Unknown Time of Onset?
Stroke 52:373-380, Simonsen, C.Z.,et al, 2021

Diffusely Enhancing Lesions on MRI in DPPX Antibody-Associated Encephalitis
JAMA Neurol 8:418-419, Liu,M.,et al, 2024

Eye Toward Stroke Prevention:Central Retinal Artery Occlusion and Tandem Internal Carotid Artery Occlusion
Stroke 55:e165-e168, Cheronis,C.,et al, 2024

Diffusion-Weighted Imaging Fluid-Attenuated Inversion Recovery Mismatch on Portable, Low-Field Magnetic Resonance Imaging Amont Acute Stroke Patients
Ann Neurol 96:321-331, Sorby-Adams,A.,et al, 2024

Miyazaki Syndrome as a Complication of Shunt Drainage
Ann Neurol 96:1230-1231, vanLanen,R.H.G.J., et al, 2024

A 40-Year-Old Woman Presenting with Encepatholopathy and Paraparesis
Neurol 101:e94-e98, AlSabah,A.,et al, 2023

A Young Woman with Rapidly Progressive Weakness and Paresthesia
Neurol 101:676-681, Alwakeel,S.S.,et al, 2023

Clinicopathologic Conference, Diffuse Large B-Cell Lymphoma
NEJM 386:977-986, Case 7-2022, 2022

A 37-Year-Old Man with Involuntary Movements, Gait Disturbance, and Hyperasthesia
Neurol 98:851-853, Meng, D.,et al, 2022

Magnetic Resonance Imaging or Computed Tomography for Suspected Acute Stroke: Association of Admission Image Modality with Acute Recanalization Therapies, Workflow Metrics, and Outcomes
Ann Neurol 92:184-194, Fischer, U.,et al, 2022

Clinicopathologic Conference, Granulomatosis with Polyangiitis
NEJM 387:1022-1032, Case 28-2022, 2022

Paraneoplastic Myeloneuropathies
Neurol 96:e632-e639, Shah, S.,et al, 2021

Clinicopathologic Conference, Disseminated Mycobacterium Bovis Infection
NEJM 384:651-662, Case 5-2021, 2021

Clinicopathologic Conference, Lympohplasmic Lymphoma of the CNS (Bing-Neel Syndrome)
NEJM 384:745-753, Case 6-2021, 2021

Clinicopathologic Conference, Normal Pressure Hydrocephalus
NEJM 384:1350-1358, Case 10-2021, 2021

A Brewing Back Pain
NEJM 385:66-72, Pischel, L.,et al, 2021

Immunocompetent Patient with Multiple Cranial Nerve Palsies, Ataxia, and Cognitive Decline
Neurol 94:e225-e229, Nigam, M.,et al, 2020

Reversible Diffusion-Weighted Imaging Lesions in Acute Ischemic Stroke
Neurol 94:571-587, Nagaraja, N.,et al, 2020

Delayed Nonischemic Cerebral Enhancing Lesions Post Endovascular Coil Embolization
Neurol 94:e2402-e2403, Bettin, M.V. & Southerland, A.M., 2020



Showing articles 0 to 50 of 1537 Next >>